If you have CML or Ph+ ALL
and you want to learn more,
you've come to the right place.
For people with chronic myeloid leukemia (CML) or Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL), who cannot receive any other TKI medicines or have a T315I mutation.
Learn about CML and what you may experience with ICLUSIG.
Learn what Ph+ ALL is
and how ICLUSIG can help treat it.
Support when you need it
Takeda Oncology 1Point™ is here to help you access and pay for ICLUSIG, and to answer questions about treatment.GO TO TAKEDA ONCOLOGY 1POINT